Viking Global Investors LP Charles River Laboratories International, Inc. Transaction History

Viking Global Investors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $23.2 Million - $31.5 Million	-121,079 Reduced 23.5%	394,089 $79.5 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $28.2 Million - $35.8 Million	-143,310 Reduced 21.76%	515,168 $112 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $19.2 Million - $26.3 Million	105,069 Added 18.99%	658,478 $130 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $6.48 Million - $9.6 Million	31,756 Added 6.09%	553,409 $118 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $33.6 Million - $47.6 Million	131,524 Added 33.71%	521,653 $148 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $74.7 Million - $95.4 Million	212,726 Added 119.91%	390,129 $147 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $65 Million - $80 Million	-174,465 Reduced 49.58%	177,403 $73.2 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $28.5 Million - $36 Million	-96,848 Reduced 21.58%	351,868 $130 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $112 Million - $134 Million	448,716 New	448,716 $130 Million

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.65B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.